Associated Papers
Aminoacyl-tRNA synthetases in Charcot-Marie-Tooth disease: A gain or a loss?
Zhang H et al.
Journal of Neurochemistry, 2021
Associations between Neurological Diseases and Mutations in the Human Glycyl-tRNA Synthetase.
Vinogradova ES et al.
Biochemistry. Biokhimiia, 2021
The role of tRNA synthetases in neurological and neuromuscular disorders.
Boczonadi V et al.
Febs Letters, 2018
Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.
Oprescu SN et al.
Methods (san Diego, Calif.), 2017
Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.
Nafisinia M et al.
Plos One, 2017
Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease.
Liao YC et al.
Plos One, 2015
Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
Griffin LB et al.
Human Mutation, 2014
[A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement].
Kawakami N et al.
Rinsho Shinkeigaku = Clinical Neurology, 2014
To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.
Wallen RC et al.
Current Opinion in Genetics & Development, 2013
GARS axonopathy: not every neuron's cup of tRNA.
Motley WW et al.
Trends in Neurosciences, 2010
Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome.
Rohkamm B et al.
Journal of the Neurological Sciences, 2007
Select a paper to view details